Find your next paid study

~$10 – $7,500

NRG OncologyNCT06532279

Triple Negative Breast Cancer

Monitoring Breast Cancer Immunotherapy Treatment With Advanced PET/MRI: A Pilot Study

This clinical study will investigate the utility of Fludeoxyglucose (18F) fluoromisonidazole (FMISO), in patients diagnosed with triple negative breast cancer …

University of Alabama at BirminghamNCT04861077

Advanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube Cancer+5 more

A Phase I First-in-human, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants With Advanced Solid Tumors

This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult …

NextCure, Inc.NCT06792552

~$10 – $8,750

Observational

A Pilot Study of Focal Magnetic Resonance (MR)-Guided Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

This clinical trial studies the side effects and how well magnetic resonance (MR)-guided stereotactic body radiation therapy (SBRT) works in treating patients …

Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+2 more

City of Hope Medical CenterNCT07769372

Observational

Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' (EXCAP-hEAT) Among Breast Cancer Survivors Receiving Adjuvant Endocrine Therapy.

This study evaluates the feasibility and preliminary effects of a home based exercise and activity program for individuals with cancer. Participants will engag…

Breast CancerCancer Related Fatigue

University of RochesterNCT07529353

Observational

EXERT-BC Cardio: Randomized Study of EXErcise Regimens After Treatment for Breast Cancer Utilizing Cardio or Conditioning Training

In this study, the investigators hypothesize that observed intense resistance training with conditioning elicits similar changes in body composition, muscle ma…

CancerBreast Cancer

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07739563

~$10 – $7,500

Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer

The primary objectives of the study are: 1. To delineate commonly utilized tumor metabolic alterations in ovarian cancer. These metabolic alterations will be …

Epithelial Ovarian Cancer

University of Tennessee Graduate School of MedicineNCT07764133

~$10 – $750

Phase 3

A Phase III Randomized Clinical Trial of Proton Craniospinal Irradiation Versus Involved-Field Radiotherapy for Patients With Breast Cancer or Non-Small Cell Lung Cancer Leptomeningeal Metastasis (Radiate-LM)

This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell l…

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more

Adenocarcinoma of the BreastBreast CancerTriple Negative Breast Cancer

~$10 – $7,500

NRG OncologyNCT06500481

Phase 2

STUDY OF DOSE DENSE CMF (Cyclophosphamide, Methotrexate, Fluorouracil) as an Alternative to AC (Doxorubicin, Cyclophosphamide) in 2 Regimens in EARLY STAGE BREAST CANCER for Patients Greater or Equal to 70

The purpose of this study is to find out if it is practical (feasible) to give dose-dense CMF (cyclophosphamide, methotrexate, and fluorouracil) in two standar…

Memorial Sloan Kettering Cancer CenterNCT07768436

Non-muscle-invasive Bladder Cancer

A Phase I Trial of Cancer-targeting Micelles for Non-myoinvasive Bladder Cancer

This clinical trial is to determine the safety and effectiveness of an investigational bladder cancer drug named "PLZ4-coated paclitaxel-loaded nanoscale micel…

VA Office of Research and DevelopmentNCT05519241

~$10 – $5,625

Phase 2

A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression…

Small Cell Lung Cancer

Puma Biotechnology, Inc.NCT06095505

~$10 – $8,750

Small Cell Lung Cancer Extensive StageBrain MetastasesSolid Tumor, Adult+3 more

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM): A Multi-cohort Platform Trial of Adaptive Radiotherapy Approaches in Multiple Cancer Types

To characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient res…